Literature DB >> 28248926

Erratum: The lncRNA XIST exhibits oncogenic properties via regulation of miR-449a and Bcl-2 in human non-small cell lung cancer.

.   

Abstract

Entities:  

Year:  2017        PMID： 28248926      PMCID： PMC5342673          DOI： 10.1038/aps.2017.3

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN： 1671-4083            Impact factor:   6.150


× No keyword cloud information.
  5 in total

1.  Synergetic Impact of Combined 5-Fluorouracil and Rutin on Apoptosis in PC3 Cancer Cells through the Modulation of P53 Gene Expression.

Authors:  Atefeh Satari; Sayed Asadollah Amini; Elham Raeisi; Yves Lemoigne; Esfandiar Heidarian
Journal:  Adv Pharm Bull       Date:  2019-08-01

2.  Long non-coding RNA XIST binding to let-7c-5p contributes to rheumatoid arthritis through its effects on proliferation and differentiation of osteoblasts via regulation of STAT3.

Authors:  Zong-Qiang Wang; Dian-Hui Xiu; Jin-Lan Jiang; Gui-Feng Liu
Journal:  J Clin Lab Anal       Date:  2020-09-03       Impact factor: 2.352

3.  Long non-coding RNA HOTAIR promotes the progression of synovial sarcoma through microRNA-126/stromal cell-derived factor-1 regulation.

Authors:  Qi Feng; Donglai Wang; Peng Guo; Zibo Zhang; Jiangang Feng
Journal:  Oncol Lett       Date:  2021-04-06       Impact factor: 2.967

4.  Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.

Authors:  Lin-Juan Tian; Yun-Ping Wu; Dong Wang; Zhi-He Zhou; Shou-Bin Xue; Dong-Yue Zhang; Yong-Gang Wei; Wei Liu
Journal:  Med Sci Monit       Date:  2019-10-29

5.  The lncRNA NORAD/miR-520a-3p Facilitates Malignancy in Non-Small Cell Lung Cancer via PI3k/Akt/mTOR Signaling Pathway.

Authors:  Yunyan Wan; Zhouhong Yao; Weijuan Chen; Dezhi Li
Journal:  Onco Targets Ther       Date:  2020-02-19       Impact factor: 4.147
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.